CHRONIC OBSTRUCTIVE PULMONARY DISEASE MONITORING

    公开(公告)号:US20230165522A1

    公开(公告)日:2023-06-01

    申请号:US18054035

    申请日:2022-11-09

    Inventor: Geert Morren

    Abstract: An example device includes memory configured to store a measure of COPD severity of a patient and processing circuitry communicatively coupled to the memory. The processing circuitry is configured to receive an electromyogram (EMG) of the patient, receive one or more signals indicative of respiration rate of the patient, and receive one or more signals indicative of tidal volume of the patient. The processing circuitry is configured to determine, based on the respiration rate of the patient and the tidal volume of the patient, a minute ventilation of the patient. The processing circuitry is configured to determine, based on the minute ventilation of the patient and the EMG of the patient, the measure of COPD severity of the patient, and generate an indication for output that is based at least in part on the measure of COPD severity of the patient.

    CHRONIC OBSTRUCTIVE PULMONARY DISEASE MONITORING DEVICE

    公开(公告)号:US20250017536A1

    公开(公告)日:2025-01-16

    申请号:US18707353

    申请日:2022-11-02

    Inventor: Geert Morren

    Abstract: An example device includes memory configured to store an N-dimensional model, where N is equal to a count of a plurality of physiological parameters and processing circuitry communicatively coupled to the memory. The processing circuitry is configured to determine a plurality of signals indicative of physical quantities of the patient and to process the plurality of signals indicative of physical quantities of the patient to determine a plurality of physiological parameters of the patient. The processing circuitry is configured to process the plurality of physiological parameters of the patient to the N-dimensional model to determine a chronic obstructive pulmonary disease (COPD)-exacerbation risk score and determine whether the COPD-exacerbation risk score satisfies a threshold. The processing circuitry is configured to, generate an indication for output that is based at least in part on the COPD-exacerbation risk score satisfying the threshold.

    HEMATOCRIT SENSOR BASED ON IMPEDANCE MEASUREMENT IN CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICES

    公开(公告)号:US20230136130A1

    公开(公告)日:2023-05-04

    申请号:US17955607

    申请日:2022-09-29

    Inventor: Geert Morren

    Abstract: An example device includes memory configured to store a first impedance and a second impedance each associated with a heart of a patient, and processing circuitry communicatively coupled to the memory. The processing circuitry is configured to determine at least one of a measure of hematocrit, an indication of fluid overload, or an indication of true anemia based at least in part on the first impedance and the second impedance. The processing circuitry is configured to output an indication of the measure of hematocrit, the indication of fluid overload, or the indication true anemia.

Patent Agency Ranking